Effect of Dexmedetomidine as an Adjuvant to Levobupivacaine in Spinal Anaesthesia for Infraumbilical Surgeries
Journal Title: Indian Journal of Anesthesia and Analgesia - Year 2019, Vol 6, Issue 2
Abstract
Spinal anaesthesia is the preferred mode of anaesthesia for infraumbilical surgeries. Levobupivacaine is an isomer of racemic bupivacaine. Various adjuvants have been added to the local anaesthetics to prolong its effect. In present study, we have studied different doses of dexmedetomidine used as an adjuvant to levobupivacaine in spinal anaesthesia. Background: This study aims to investigate the effect of intrathecal administration of different doses of dexmedetomidine on the onset and duration of sensory and motor block, haemodynamic alterations and adverse effects produced by spinal levobupivacaine. Methods: 75ASA I-II patients with age group 18-70 years (weight 50-70 kg) undergoing infraumbilical surgies were randomized to one of the three groups. Every patient received 3.3 ml of drug intrathecally that consisted of 15 mg (3 ml of 0.5%) preservative free levobupivacaine containing either 0.3 ml normal saline (Group L) as control group, dexmedetomidine 15 μg (Group LD1) or dexmedetomidine 30 μg (Group LD2). Onset and duration of sensory and motor block, maximum sensory level achieved, sedation levels, haemodynamic parameters and adverse effects were recorded. Analysis of data between groups was performed using one way analysis of variance test (ANOVA test), student t-test and chi-square test (whichever was applicable). Results: Dexmedetomidine significantly shortens the onset of sensory and motor block and prolonged the time to two segment regression and regression of motor block to modified Bromage 0. In addition group LD2 had higher sedation scores. There was higher incidence of hypotension, bradycardia and respiratory depression in group LD2. Conclusion: Intrathecaldexmedetomidine in a dose of 15 μg significantly prolongs the anaesthetic effects of intrathecallevobupivacaine without significant side effects. So, 15 μg is the preferred dose of dexmedetomidine over 30 μg, when used as an adjuvant to levobupivacaine in spinal anaesthesia.
Authors and Affiliations
Sofia Jaswal
Intrathecal Hyperbaric Bupivacaine and Isobaric Levobupivacaine for Spinal Anaesthesia: Block Characteristics and Clinical Effects
Introduction: Bupivacaine (0.5% heavy) is used to administer subarachnoid block but carries an increased risk of cardiac and central nervous system toxicity if inadvertently injected intravascularly. Levobupivacaine is S...
A Prospective Randomised Controlled Study of Pre-Emptive Oral Flupirtine on Postoperative Analgesia in Patients Undergoing Abdominal Surgeries Under General Anesthesia
Introduction: Flupirtine is non-opioid, non-NSAID, centrally acting indirect NMDA receptor antagonist. It's analgesic effect is equivalent to NSAIDs and opioids with devoid of their side effects. Abdominal surgeries are...
A Prospective Comparative Study of 0.5% Levobupivacaine versus 0.5% Ropivacaine in Supraclavicular Brachial Plexus Block
Background: Levobupivacaine is a s enantiomer of bupivacaine has been introduced in clinical practise in India, with lower cardio toxicity and neurotoxicity in comparison to bupivacaine [7,8]. We have designed present st...
An Observational Study to Compare Intrathecal Midazolam and Clonidine for Post Operative Analgesia in Patients Undergoing Elective Hernia Surgeries
This observational study is designed to compare the intrathecal preservative free midazolam and clonidine, used as an adjuvant with hyperbaric bupivacaine for post operative analgesia in patients undergoing elective her...
To assess the Compliance and Sedation Score of Intranasal Midazolam and dexmedetomedine Premedication among Children
Background: The pre anesthetic medication forms an integral part of anesthetic management. Some form of premedication is almost universally given before induction of anesthesia. In ancient days both wine and opium were g...